Sabo, John P <br/><br/>
Effect of the hepatitis C virus protease inhibitor faldaprevir on the pharmacokinetics of an oral contraceptive containing ethinylestradiol and levonorgestrel in healthy female volunteers.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  Jan 2015 
 - 514-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1098-6596 
<br/><br/><label>Standard No.: </label>10.1128/AAC.03589-14  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adolescent<br/>Adult<br/>Aminoisobutyric Acids<br/>Area Under Curve<br/>Bilirubin--blood<br/>Contraceptives, Oral, Combined--administration & dosage<br/>Drug Combinations<br/>Drug Interactions<br/>Ethinyl Estradiol--administration & dosage<br/>Female<br/>Half-Life<br/>Humans<br/>Leucine--analogs & derivatives<br/>Levonorgestrel--administration & dosage<br/>Oligopeptides--administration & dosage<br/>Proline--analogs & derivatives<br/>Protease Inhibitors--administration & dosage<br/>Quinolines<br/>Thiazoles--administration & dosage<br/>Viral Nonstructural Proteins--antagonists & inhibitors<br/>Young Adult